Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
StimAire has developed a rice-grain-sized, battery-free injectable neurostimulator that is placed near the hypoglossal nerve via a minimally invasive procedure under local anesthesia. The system is activated by an external wearable patch at night to treat obstructive sleep apnea. In its first-in-human clinical study, the device demonstrated safety with no adverse events or significant discomfort, and efficacy as measured by increased sleep duration and REM sleep in OSA patients. The company has received FDA Breakthrough Device Designation and is advancing toward pivotal trials and commercialization[2][5][6].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on StimAire.